Investors

At Adamas Pharmaceuticals, Inc, our purpose and vision are clear: deliver innovative medicines that make everyday life significantly better for patients, caregivers and society

Patricia, person with Parkinson’s, creative scrapbooker

Investors

We are an emerging, fully-integrated company focused on neurological diseases with a proven track record of turning this purpose into reality by combining expertise in development and commercialization with a passion for improving lives.

Latest quarterly results

Press release

February 23, 2021
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
View

Form 10-K

Filing date Description Form View

Annual report which provides a comprehensive overview of the company for the past year

 10-K View HTML
0001047469-15-001576.pdf
0001047469-15-001576.rtf
0001047469-15-001576.xls
EX-101.INS - EX-101.INS
View

Webcast

February 23, 2021 | 4:30 PM EST
Adamas Fourth Quarter 2020 Financial Results
View

News and events

Press releases
View all
Recent events
View all

Stock information

Feb 25, 2021 12:07 AM EST Data Provided by Refinitiv. Minimum 15 minutes delayed.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Quick links